Pros and cons of using interleukin‐2 receptor antibodies in liver transplant recipients
Ryutaro Hirose – 30 December 2003
Current practice regarding the use of fatty livers: A Trans‐Atlantic survey
Charles J. Imber, Shawn D. St. Peter, Inigo Lopez, Lynden Guiver, Peter J. Friend – 30 December 2003 – A strong association exists between the presence of steatosis in a donor liver for transplantation and the development of primary nonfunction in the recipient. Despite this, appraisal of the donor remains one of the least scientific aspects of the transplantation process, and many centers base their practice on subjective opinion, rather than objective data.
Hepatic steatosis and its relationship to transplantation
Charles J. Imber, Shawn D. St. Peter, Ashok Handa, Peter J. Friend – 30 December 2003 – Fatty infiltration of the liver is common in the brain‐dead donor population and has a strong correlation with primary nonfunction after cold preservation, a condition that is catastrophic to liver transplant recipients. This literature review examines factors associated with the development, diagnosis, quantification, and clinical management of this difficult condition.
Unsuspected primary hepatic angiosarcoma associated with portal vein thrombosis complicating cirrhosis
Silvania K. Pimentel Cauduro, Lydia M. Petrovic, Thomas C. Sodeman, Michael Brian Ishitani, K.V. Narayanan Menon, J. Eileen Hay – 30 December 2003
Pulmonary gas exchange abnormalities in liver transplant candidates
Rosmawati Mohamed, Jonathan W. Freeman, Peter J. Guest, Michael K. Davies, James M. Neuberger – 30 December 2003 – Abnormal diffusing capacity is the commonest pulmonary dysfunction in liver transplant candidates, but severe hypoxemia secondary to hepatopulmonary syndrome and significant pulmonary hypertension are pulmonary vascular manifestations of cirrhosis that may affect the perioperative course. We prospectively assessed the extent of pulmonary dysfunction in patients referred for liver transplantation. A total of 57 consecutive patients with chronic liver disease were evaluated.
Reduced use of intensive care after liver transplantation: Patient attributes that determine early transfer to surgical wards
M. Susan Mandell, Dennis Lezotte, Igal Kam, Stacy Zamudio – 30 December 2003 – Part 1 of our report, presented in the same issue of the Journal, shows that immediate postoperative extubation and direct transfer to the surgical ward is safe and reduces reliance on the intensive care unit in most liver transplant recipients. However, there is no method to preoperatively predict which patients will need ventilatory support after surgery.
Liver transplantation in association with hepatocellular carcinoma: An update of the international tumor registry
Ernesto P. Molmenti, Goran B. Klintmalm – 30 December 2003 – Hepatocellular carcinoma is an epithelial tumor derived from hepatocytes that accounts for more than 80% of all primary hepatic tumors. The severity of the underlying disease is almost always the key factor in deciding whether to consider liver resection or transplantation as its treatment.
Detection of albumin synthesis in transplanted porcine hepatocytes in mice
Ryuta Nishitai, Timothy B. Plummer, Jeffrey L. Platt – 30 December 2003
In pursuit of the ideal liver allocation model
Richard B. Freeman – 30 December 2003
An examination of factors predicting prioritization for liver transplantation
Andrew J. Muir, Linda L. Sanders, Michael A. Heneghan, Paul C. Kuo, William E. Wilkinson, Dawn Provenzale – 30 December 2003 – With the recent transition of the liver transplant allocation system to the Model for End‐Stage Liver Disease, a major change is its reliance entirely on objective criteria. In previous reports, potential donor families and members of the transplant community have questioned the fairness of the subjective nature of previous systems.